Caricamento...
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Chimeric antigen receptor (CAR)-modified T cells and bispecific T cell–engaging antibodies have demonstrated dramatic clinical responses in recent clinical trials. The hallmark of these novel highly active immunotherapies is nonphysiologic T cell activation, which has correlated not only with greatl...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4119809/ https://ncbi.nlm.nih.gov/pubmed/24667956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000035 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|